Health care stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) 0.4% higher.

Eupraxia Pharmaceuticals (EPRX) shares were up more than 1% after the company said data from its ongoing trial evaluating EP-104GI for eosinophilic esophagitis treatment showed 59% of patients achieved clinical remission at 12 weeks.

Monte Rosa Therapeutics (GLUE) stock was down 1% after the company reported that it swung to a Q4 net loss as collaboration revenue declined during the period.

Lensar (LNSR) shares were down more than 24% after the company said it has reached an agreement with Alcon (ALC) to terminate their planned merger.